MedTech Venture Partners is a venture capital firm based in Menlo Park, California, focused on seed and early-stage medical device companies developing novel therapeutic and diagnostic technologies. The firm's team brings extensive operational experience in medical device development, launch, and scaling.
86% of their portfolio is in Healthcare. Average disclosed round size is $50.7M (across 6 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Zenflow | Series D | $52M | Oct 2026 |
 GT Medical Technologies | Series D | $37M | Jan 2025 |
| GT Medical Technologies | Series C | $45M | Mar 2023 |
 Reyedar | Seed | — | Jan 2023 |
 Oxford Immune Algorithmics | Seed | $10M | Jan 2021 |
| PPQ Bypass | Series C | $60M | Jan 2019 |
| GT Medical Technologies | Series E | $100M | — |
Top Co-Investors
Gilde Healthcare3 shared
Lightspeed Venture Partners3 shared
VMG Partners2 shared
Evidity Health Capital2 shared
Nexus Venture Partners1 shared
Bluestone Equity Partners1 shared
Cottonwood Technology Fund1 shared
Uneti Ventures1 shared
Accelmed Partners1 shared
Viking Global Investors1 shared
Seroba Life Sciences1 shared
Deerfield1 shared
SFC Capital1 shared
F-Prime Capital1 shared
HSBC1 shared
ClavystBio1 shared
Y Combinator1 shared
Trinity Capital Inc.1 shared
Last updated: 20 October 2026